E-drug: Availability of Analgin in Nepalese Market after being banned
---------------------------------------------------------------------
[titled slightly edited to fit E-drug message; WB]
Availability of Analgin and its Combination in Nepalese Market After
[being] Banned.
by Kafle K.k, Bhuju G.B, Shrestha B.M, DC Gorkha, Humagain B.R, Rajbhandari
V,Thapa B.B, Prasad R.R, Karkee S.B
Abstract: His Majesty's Government of Nepal (HMG) banned Analgin
(Metamizole) and its combination for sale from January 1998. A study
was conducted with the objective of finding out availability of
Analgin and its combination in the market following banning of the
products. The study covered randomly selected 113 drug retailers from
29 clusters of three districts of Kathmandu valley. The study used
surrogate technique for data collection. Analgin and its combination
were available with about 97% of drug retailers before [being] banned.
The availability was reduced to about 88%, 20% and 0% after one
month, five months and 16 months respectively. To conclude, drug
regulatory authority should take different measures to stop sale and
distribution of banned products.
Kafle K.k, Bhuju G.B, Shrestha B.M, DC Gorkha, Humagain B.R, Rajbhandari
V,Thapa B.B, Prasad R.R, Karkee S.B
Pharmaceutical Horizon of Nepal (PHON),
GPO Box No 9566,
Kathmandu,
Nepal
E-mail:inrud@healthnet.org.np
[Compliments for the applied research and sending an abstract to E-drug!
What other measures could have been taken? A recall? Would that work among
informal traders? At least the study showed that metamizole was finally
removed from the market after a decision by the Regulatory Authority. WB]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.